Clinical Trial Update: Etude (Study) Phase I Enox - UnFractionated Heparin (UFH) [Phase 1]

View source ↗

Summary

Sanofi-sponsored Phase I trial evaluating unfractionated heparin (UFH) for thrombosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Sanofi | Conditions: Thrombosis | Phase 1 | Status: COMPLETED